GNPTAB p.Ser15Pro
c.43T>C · rs2547989570 · VCV2444222
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9847 | likely pathogenic · top 9% in GNPTAB |
|---|---|---|
| REVEL | 0.582 | indeterminate |
| SaProt | LLR -10.81 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · A>C here scores Δ0.34 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 8.6 | GERP 1.3, phastCons 1 |
| Regional constraint | o/e 0.89 | unconstrained · MANE · 84 kb · p 4.2e-05 · regional, not allelic |
| Overall | ||
| CADD | 25.0 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- GNPTAB
- Protein
- p.Ser15Pro
- Coding
- c.43T>C
- MANE Select
- NM_024312
- dbSNP
- rs2547989570
- Type
- single nucleotide variant
- Location
- chr12:101830633 (GRCh38)
- Gene constraint
- LOEUF 0.8 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 72.15 · 5 PDB
- Residue 15
- a UniProt-annotated variant site (in mliiia; uncertain significance; no effect on protein abundance; decreased protein cleavage into alpha and beta subunits; decreased retention in the golgi; mistargeted to lysosomes and plasma membrane; decreased udp-n-acetylglucosamine-lysosomal-enzyme n-acetylglucosaminephosphotransferase activity)
Disease context
mucolipidosis type III, alpha/beta — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: mucolipidosis type II
For Mucolipidosis type III (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- GNPTAB p.Ser15Tyr Likely pathogenic ★ ⚠ same residue
- GNPTAB c.118-1G>A Pathogenic/Likely pathogenic ★★ same condition
- GNPTAB c.118-2A>G Pathogenic/Likely pathogenic ★★ same condition
- GNPTAB c.1284+1G>T Pathogenic/Likely pathogenic ★★ same condition
- GNPTAB c.1408+1G>T Pathogenic/Likely pathogenic ★★ same condition
- GNPTAB c.1409-2A>G Pathogenic/Likely pathogenic ★★ same condition
- GNPTAB c.2715+1G>A Pathogenic ★★ same condition
- GNPTAB c.2715+2T>G Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gnptab-p-ser15pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown